October 12, 2015 / 5:33 AM / in 2 years

BRIEF-Hepalink Pharma's US unit plans to invest in Quest PharmaTech, OncoQuest

Oct 12 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd

* Says its U.S. unit, Hepalink USA Inc, plans to invest C$2 million in Quest PharmaTech Inc by subscribing 25 million new shares

* Says its U.S. unit, Hepalink USA Inc, plans to invest $13 million in OncoQuest Inc by subscribing preference shares

* Says plans to invest $5 million to set up JV in China with OncoQuest Inc

Source text in Chinese: bit.ly/1VN1q0f

Further company coverage:

Reporting by Hong Kong and Singapore newsrooms

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below